
Neetu Chandra Sharma is a Senior Editor at Business Today, where she leads the magazine’s coverage of healthcare and pharmaceuticals. With o...

New global guidance also recommends tackling obesity, diabetes, and hearing loss; AIIMS and NIMHANS experts contributed to the report

The healthcare major says India will anchor global support operations as it expands hospitals, diagnostics, and health-tech investments

PB Fintech has opened its first hospital in Gurugram as it seeks to bring medical care, insurance and technology together under the PB Health brand.
Dr. Reddy's Laboratories has announced a delay in the commercial supply of its semaglutide drug after identifying an issue with the active pharmaceutical ingredient (API) in certain batches. In this v...

India becomes seventh market for Awiqli as drugmaker targets delays in insulin initiation among people with diabetes.

WHO warns global cancer cases to hit 35 million by 2050. Nearly 40% of cancers are preventable, but rising obesity, physical inactivity and unequal access to care threaten progress.

After spending nearly Rs 6,800 crore and more than two decades, Wockhardt has achieved what no Indian pharmaceutical company has before: US FDA approval for a novel drug discovered and developed in-ho...
Novo Nordisk has launched Awiqli (insulin icodec), the world’s first once-weekly basal insulin, in India. The company says the therapy could reduce the injection burden from 365 to 52 annually and hel...
India's weight-loss drug market is entering a new phase. According to Pharmatrac's June Indian Pharmaceutical Market data, the rapid expansion of the injectable semaglutide market has started to slow ...

Hospital chain signs O&M agreement with Dion Group for greenfield multi-speciality facility in Cuttack as it expands beyond its existing markets.




